Cel Sci CVM
NYSE CVM
$1.63 +0.01 (+0.62%)
As of: Oct 22, 2026 · 12:30 PM EDT

Cel Sci (CVM) Other Investing Activities (2010 - 2011)

Updated

Analysis

Cel Sci (CVM) Other Investing Activities (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn 407.00 Mn
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn -51.00 Mn
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn 174.00 Mn
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -1.00 Mn
10 Cel Sci 2.93 Mn -22.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 21,372.00
Dec 31, 2010 -15.00
Sep 30, 2010 94,410.00
API Access

Cel Sci Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=CVM&period=max&api_key=YOUR_API_KEY